Kimia Biosciences

Kimia Biosciences

37.38
-1.08
(-2.81%)
Market Cap
182.00 Cr
EPS
2.03
PE Ratio
20.68
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
86.85
52 Week Low
35.10
PB Ratio
18.27
Debt to Equity
16.69
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,641.80
#1 3,93,538.90
34.30
#1 54,729.00
9.71
#1 10,980
-19.84
47.84
6,151.50
1,60,024.50
69.37
9,712.00
18.67
2,191
26.74
42.63
1,592.80
1,28,651.70
23.86
28,409.50
7.12
5,291
9.88
66.07
3,685.30
1,23,444.60
61.13
11,539.40
6.99
1,911
19.91
62.55
2,606.80
1,07,313.60
56.78
12,744.20
#1 20.90
2,007
-18.14
60.80
1,277.60
1,06,541.30
#1 18.75
33,741.20
16.73
5,725
1.26
57.55
988.80
99,194.50
21.29
23,511.00
18.55
4,615
2.60
57.27
1,974.70
89,626.50
24.22
22,909.50
13.74
3,306
#1 51.64
55.21
31,875.00
69,347.10
47.71
6,684.70
9.64
1,414
11.55
39.14
5,426.00
64,828.10
28.51
13,458.30
3.70
2,216
21.39
70.80
Forecast
Actual
Growth Rate
Revenue Growth
-17.89 %
Net Income Growth
-43.62 %
Cash Flow Change
314.62 %
ROE
836.82 %
ROCE
-61.45 %
EBITDA Margin (Avg.)
-137.59 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
2
0
2
77
95
107
135
126
130
107
119
122
Expenses
4
4
2
74
88
102
124
124
134
105
99
101
EBITDA
-1
-3
-0
3
7
5
11
2
-4
1
20
21
Operating Profit %
-110 %
-1,759 %
-67 %
3 %
6 %
4 %
6 %
1 %
-4 %
-0 %
17 %
15 %
Depreciation
0
0
0
1
1
2
2
3
3
3
3
3
Interest
0
1
0
1
2
3
3
4
4
5
5
5
Profit Before Tax
-2
-4
-1
2
4
1
6
-5
-12
-7
14
13
Tax
0
0
-0
-0
0
-0
0
-1
-3
-2
0
-0
Net Profit
-2
-4
-1
2
4
1
5
-4
-9
-5
14
9
EPS in ₹
-2.31
-5.49
-1.26
1.14
2.64
0.33
1.08
-0.78
-1.98
-1.12
2.03
1.90

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
5
4
12
58
65
86
107
110
121
100
111
Fixed Assets
3
3
7
13
16
18
28
35
34
32
33
Current Assets
1
1
2
43
48
61
72
73
83
61
75
Capital Work in Progress
0
0
3
3
2
6
6
0
1
1
0
Investments
0
0
0
0
0
0
0
0
0
0
35
Other Assets
1
1
2
43
48
62
73
74
87
68
0
Total Liabilities
5
4
12
58
65
86
107
110
121
100
111
Current Liabilities
4
1
7
31
30
39
51
62
76
69
82
Non Current Liabilities
1
7
9
25
29
34
37
33
40
30
19
Total Equity
0
-4
-5
2
6
13
18
15
6
0
10
Reserve & Surplus
-7
-11
-12
-2
2
9
14
10
1
-4
5
Share Capital
7
7
7
2
2
5
5
5
5
5
5

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
0
1
-1
0
0
-0
0
0
Investing Activities
0
-0
-6
-2
-2
-9
-14
-1
-3
-2
Operating Activities
0
-6
-1
-7
-3
0
6
8
-7
15
Financing Activities
-0
6
7
10
4
9
8
-8
10
-13

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
23.16 %
23.15 %
23.15 %
23.09 %
23.16 %
0.00 %
23.20 %
23.11 %
23.10 %
23.04 %
23.04 %
23.04 %
23.05 %
23.05 %
23.03 %
22.94 %
23.04 %
23.04 %
Others
1.52 %
1.52 %
1.52 %
1.59 %
1.51 %
24.68 %
1.48 %
1.57 %
1.58 %
1.64 %
1.64 %
1.64 %
1.63 %
1.63 %
1.65 %
1.74 %
1.64 %
1.64 %
No of Share Holders
11,912
12,192
12,173
12,212
12,510
12,454
12,399
12,243
12,201
12,147
12,118
12,063
12,110
12,023
12,179
12,231
12,278
12,200

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
04 Jan 2019 CHANGE OF NAME Change Of Name
NA
04 Jan 2019 39.90 39.90
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 48.72 46.88
30 Dec 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Dec 2025 49.79 45.00
13 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Feb 2025 47.04 43.25
26 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 May 2025 40.50 42.10
22 Jul 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
22 Jul 2025 50.41 70.47
14 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Aug 2025 46.31 43.00

Announcements

Revised Outcome Of Board Meeting Dated 14.08.20251 day ago
Announcement under Regulation 30 (LODR)-Newspaper Publication6 days ago
Announcement under Regulation 30 (LODR)-Change in Management8 days ago
Board Meeting Outcome for Board Meeting Outcome For Board Meeting Held Today On 14 Auguest20258 days ago
Financial Results For The Quarter Ended June 30 20258 days ago
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 On Thursday August 14 2025 At 12:00 P.M.Aug 08, 2025
Disclosure under Regulation 30A of LODRAug 04, 2025
Disclosure under Regulation 30A of LODRJul 31, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJul 24, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMJul 23, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
ANNOUNCEMENT UNDER REGULATION 30(LODR) REGARDING THE CLARIFICAION -PRICE MOVEMENTJul 02, 2025
Clarification sought from Kimia Biosciences LtdJul 02, 2025
Intimation Of Newspaper Advertisement Of Extraordinary General Meeting And E-Voting Information. Jul 01, 2025
NOTICE OF EXTRA-ORDINARY GENERAL MEETING OF KIMIA BIOSCIENCES LIMITEDJun 29, 2025
Intimation Of Extra-Ordinary General Meeting Scheduled To Be Held On 22 July2025Jun 29, 2025
Closure of Trading WindowJun 28, 2025
INTIMATION FOR THE APPOINTMENT OF INTERNAL AUDITOR FOR THE FINANCIAL YEAR 2025-2026Jun 25, 2025
INTIMATION FOR THE APPOINTMENT OF SECRETARIAL AUDITOR FOR THE FINANCIAL YEAR 2024-2025Jun 25, 2025
INTIMATION FOR THE APPOINTMENT OF ADDITIONAL DIRECTOR REGULARISATION WILL BE DONE IN ENSUING EGM SCHEDULED TO BE HELD ON 22 JULY2025Jun 25, 2025
INTIMATION FOR THE APPOINTMENT OF COST AUDITORJun 25, 2025
Disclosure under Regulation 30A of LODRJun 25, 2025
Disclosure under Regulation 30A of LODRJun 25, 2025
Disclosure under Regulation 30A of LODRJun 25, 2025
Disclosure under Regulation 30A of LODRJun 25, 2025
Board Meeting Outcome for Board Meeting Outcome As Per Regulation 30SEBI(LODR)Jun 25, 2025
Reg. 34 (1) Annual Report.Jun 24, 2025
Detailed Reasons For Delay In Submission Of Financial Results For Period/Year Ended March 31 2025. With Reference To The Communication Regarding The Delay In Submitting The Financial Results For The Quarter And Financial Year Ended On 31St March 2025 DatJun 23, 2025
INTIMATION OF BOARD MEETING UNDER REGULATION 29(1)(D) OF SEBI (LODR) REGULATIONS2015Jun 20, 2025
Revised Board Meeting Outcome Held On 26 May2025 Document For The Quarter And Financial Year Ended On 31St March 2025 (Regulation 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements)Regulations 2015Jun 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 31, 2025
Non-Applicability Of Regulation 24A Of SEBI(Listing Obligation And Disclosure )Regulations2015May 29, 2025
Financial Results Ended On 31 March 2025May 28, 2025
Newspaper Publication Of Financial Results As Per Regulation 30 Of Securities Exchange Board Of India2015May 28, 2025
Integrated Filing (Financial)May 26, 2025
Board Meeting Outcome for Outcome Of The Financials In The Board MeetingMay 26, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AMay 23, 2025
Board Meeting Intimation for Approval Of Audited Financials For The Quarter And Financial Year Ended On 31St March 2025May 21, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 05Th May 2025 Pursuant To Regulation 30 Of SEBI (LODR) Regulations 2015May 05, 2025
Board Meeting Intimation for Payment To Redeemable Preference SharesMay 01, 2025
Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsApr 23, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Apr 23, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sApr 23, 2025
Board Meeting Outcome for Outcome Of Board Meeting 23.04.2025Apr 23, 2025
Statement Of Investor Complaint Regulation 13(3) Of SEBI LODR2015Apr 19, 2025
Board Meeting Intimation for Board Meeting Intimation To Take Note Of Resignation Of Statutory Auditor And Fill The Casual Vacancy .Apr 19, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 18, 2025
Non-Applicability Of Corporate Governance Report.Apr 16, 2025
Disclosure Under Regulation 31(4) & (5) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 2011 For The Financial Year Ended March 31 2025Apr 04, 2025
Closure of Trading WindowMar 26, 2025

Technical Indicators

RSI(14)
Neutral
23.45
ATR(14)
Less Volatile
3.53
STOCH(9,6)
Oversold
11.30
STOCH RSI(14)
Oversold
12.49
MACD(12,26)
Bearish
-1.19
ADX(14)
Strong Trend
41.63
UO(9)
Bearish
30.17
ROC(12)
Downtrend And Accelerating
-28.78
WillR(14)
Oversold
-97.55